Nymox Pharmaceutical NYMXF
OTC NYMXF
$0.04 -0.02 (-33.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Nymox Pharmaceutical (NYMXF) Return on Sales [ROS] (2017 - 2020)

Updated

Nymox Pharmaceutical (NYMXF) recorded Return on Sales [ROS] of -234380.00% in Q4 2020, down 223968.46 percentage points from -10411.54% a year earlier and down 194344.52 percentage points from the prior quarter.

Analysis

Nymox Pharmaceutical (NYMXF) Return on Sales [ROS] (2017 - 2020) Analysis & Trends

For FY2020, Nymox Pharmaceutical reported Return on Sales [ROS] of -234400.00%, down 222912.93 percentage points from FY2019.

  • Annual Return on Sales [ROS] has a five-year change of -233760.38 percentage points (FY2015 to FY2020).
  • Across earlier years, Return on Sales [ROS] came in at -11487.07% in FY2019 (-7928.21 pp), -3558.86% in FY2018 (+2349.62 pp), -5908.48% in FY2017 (-1377.14 pp) and -4531.34% in FY2016 (-3891.71 pp).
  • The Q4 2020 figure is the lowest quarterly Return on Sales [ROS] in data going back to Q1 2017.
  • On a year-over-year basis, Return on Sales [ROS] rose in three of the last eight quarters, with an average year-over-year change of -39551.54 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 26105.56 percentage points in Q2 2018, against a drop of 223968.46 percentage points in Q4 2020 at the low end.
  • Per Business Quant, the preceding three quarters came in at -40035.48% (Q3 2020), -15390.00% (Q2 2020) and -52620.00% (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 Nymox Pharmaceutical 6.12 Mn 5.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -234,380.00%
Sep 30, 2020 -40,035.48%
Jun 30, 2020 -15,390.00%
Mar 31, 2020 -52,620.00%
Dec 31, 2019 -10,411.54%
Sep 30, 2019 -6,425.64%
Jun 30, 2019 -25,995.00%
Mar 31, 2019 -9,710.00%
Dec 31, 2018 -14,489.47%
Sep 30, 2018 -7,025.00%
Jun 30, 2018 -2,750.00%
Mar 31, 2018 -1,748.68%
Dec 31, 2017 -3,151.43%
Sep 30, 2017 -14,732.26%
Jun 30, 2017 -28,855.56%
Mar 31, 2017 -3,541.03%
API Access

Nymox Pharmaceutical Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NYMXF&period=max&api_key=YOUR_API_KEY